Askpot
← Company directory

Open Targets: Summary

Open Targets is a public-private partnership dedicated to transforming drug discovery by systematically identifying and prioritizing therapeutic targets. It utilizes human genetics and genomics data to support the development of safe and effective drugs.

Service Name

Open Targets

Industry

Pharmaceutical, Drug Discovery, Biotechnology, Genomics

Main Value Proposition

Open Targets provides a freely-available, comprehensive platform that aggregates public data to facilitate the identification and prioritization of therapeutic drug targets.

Description

Open Targets is a public-private partnership dedicated to transforming drug discovery by systematically identifying and prioritizing therapeutic targets. It utilizes human genetics and genomics data to support the development of safe and effective drugs.

Key Features

Open Targets Platform: A comprehensive tool for identifying and prioritizing drug targets.; Open Targets Genetics: Highlights variant-centric statistical evidence for drug target identification.; Systematic experimental approaches: Supports target identification and validation.; Rapid publication: Ensures data and results are publicly available quickly.

Use Cases

Identifying potential drug targets for various diseases.; Prioritizing candidate causal variants in genetic research.; Supporting researchers in oncology, neurodegeneration, and immunity.

Competitive advantages

Access to a wide range of public domain data for comprehensive analysis.; Collaboration with a consortium of expert partner institutions.; Commitment to rapid publication and open collaboration, fostering innovation.

Strengths

Open Targets excels in integrating diverse data sources, providing systematic methodologies for drug target identification, and maintaining a strong collaborative network.

Positioning

Open Targets positions itself as a leader in the drug discovery field by leveraging human genetics and genomics to systematically identify drug targets.

Audience

The primary audience includes researchers in drug discovery, geneticists, and pharmaceutical companies looking for reliable data on therapeutic targets.

CTA

Visit the Open Targets Platform

Tags
  • drug discovery

  • genomics

  • therapeutic targets

  • open source

Tagline

Developing safe and effective drugs is difficult and expensive

Tone of Voice

Innovative, collaborative, authoritative

Differentiation

Open Targets uniquely combines large-scale human genetics data with systematic experimental approaches, setting it apart from other drug discovery initiatives.

Brand Positioning

Open Targets is recognized as an innovative and collaborative initiative that prioritizes transparency and accessibility in drug discovery.

Founded

2016-04-01